产品编号 :
Cas No. :
CAS No. |
2376894-10-7 |
|---|---|
英文名称 |
MC-1-F2 |
别名 |
MC-1-F2;Guanidine, N-[4-[[4-[4-[4-amino-6-[[4-(4-morpholinyl)phenyl]amino]-1,3,5-triazin-2-yl]-1-piperazinyl]-6-[(4-phenoxyphenyl)amino]-1,3,5-triazin-2-yl]amino]butyl]- |
标准英文名 |
2-(4-((4-(4-(4-amino-6-((4-morpholinophenyl)amino)-1,3,5-triazin-2-yl)piperazin-1-yl)-6-((4-phenoxyphenyl)amino)-1,3,5-triazin-2-yl)amino)butyl)guanidine |
MDL No. |
MFCD35065849 |
分子式 |
C37H46N16O2 |
分子量 |
746.89 |
精确分子量 |
746.40 |
SMILES |
NC(NCCCCNC1=NC(N2CCN(C3=NC(N)=NC(NC4=CC=C(N5CCOCC5)C=C4)=N3)CC2)=NC(NC6=CC=C(OC7=CC=CC=C7)C=C6)=N1)=N |
标准SMILES |
NC1N=C(N=C(NC2=CC=C(C=C2)N2CCOCC2)N=1)N1CCN(CC1)C1N=C(NCCCCNC(N)=N)N=C(NC2=CC=C(C=C2)OC2=CC=CC=C2)N=1 |
用途 |
MC-1-F2 is a FOXC2 inhibitor that reduces epithelial-mesenchymal transition (EMT) markers in breast cancer cell lines, suppresses cancer stem cell (CSC) properties, and decreases the invasive capacity of castration-resistant prostate cancer (CRPC) cell lines; it exhibits synergistic effects with docetaxel and holds potential for combination therapy in CRPC research. |
InChIKey |
COSUURDQUHTOIY-UHFFFAOYSA-N |
|
|
评论 |
|---|